Alban Bessede

Aryl hydrocarbon receptor control of a disease tolerance defence pathway

Alban Bessede, Marco Gargaro, Maria Teresa Pallotta et al. · Nature · 2014 · 657 citations · Full text

Disease Mechanism, Medicine, Immunology +8

Mature tertiary lymphoid structures predict immune checkpoint inhibitor efficacy in solid tumors independently of PD-L1 expression

Lucile Vanhersecke, Maxime Brunet, Jean‐Philippe Guégan et al. · Nature Cancer · 2021 · 515 citations · Full text

Lymphoid Neoplasia, Cancer Immunosurveillance, Pd-l1 Expression +9

Use of PD-1 Targeting, Macrophage Infiltration, and IDO Pathway Activation in Sarcomas

Maud Toulmonde, Nicolas Penel, Julien Adam et al. · JAMA Oncology · 2017 · 381 citations · Full text

The kynurenine pathway is activated in human obesity and shifted toward kynurenine monooxygenase activation

Marie Favennec, Benjamin Hennart, Robert Caïazzo et al. · Obesity · 2015 · 269 citations

Metabolic Disorder, Human Obesity, Metabolic Remodeling +26

Kynurenine pathway metabolomics predicts and provides mechanistic insight into multiple sclerosis progression

Chai K. Lim, Ayse Bilgin, David B. Lovejoy et al. · Scientific Reports · 2017 · 240 citations · Full text